Açıklama

Summary of gut microbiome biomarkers associated with therapeutic response in inflammatory bowel disease. The systematic review identifies microbial signatures that may predict outcomes of advanced therapies in IBD patients.

Figure 4

Chart

Source Paper

Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review.

Gut microbes (2023)

PMID: 38044504

DOI: 10.1080/19490976.2023.2287073

Cite This Figure

![Figure 4: Summary of gut microbiome biomarkers associated with therapeutic response in inflammatory bowel disease. The systematic review identifies microbial signatures that may predict outcomes of advanced therapies in IBD patients.]()

> Source: Susanna Meade et al. "Gut microbiome-associated predictors as biomarkers of response to advanced thera." *Gut microbes*, 2023. PMID: [38044504](https://pubmed.ncbi.nlm.nih.gov/38044504/)

<figure>
  <img src="" alt="Summary of gut microbiome biomarkers associated with therapeutic response in inflammatory bowel disease. The systematic review identifies microbial signatures that may predict outcomes of advanced therapies in IBD patients." />
  <figcaption>Figure 4. Summary of gut microbiome biomarkers associated with therapeutic response in inflammatory bowel disease. The systematic review identifies microbial signatures that may predict outcomes of advanced therapies in IBD patients.<br>  Source: Susanna Meade et al. "Gut microbiome-associated predictors as biomarkers of response to advanced thera." <em>Gut microbes</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38044504/">38044504</a></figcaption>
</figure>

İlgili Kanıtlar

Butyrate (Sodium/Calcium Butyrate) için Ulcerative Colitis (UC)

Derece C · 3 çalışma